Peer Review reports
From: PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models
| Original Submission | ||
|---|---|---|
| 19 Sep 2022 | Submitted | Original manuscript |
| 21 Oct 2022 | Reviewed | Reviewer Report |
| 22 Oct 2022 | Reviewed | Reviewer Report |
| 22 Nov 2022 | Author responded | Author comments - Ki Cheong Park |
| Resubmission - Version 2 | ||
| 22 Nov 2022 | Submitted | Manuscript version 2 |
| 24 Nov 2022 | Reviewed | Reviewer Report |
| 7 Dec 2022 | Reviewed | Reviewer Report |
| 15 Dec 2022 | Author responded | Author comments - Ki Cheong Park |
| Resubmission - Version 3 | ||
| 15 Dec 2022 | Submitted | Manuscript version 3 |
| Publishing | ||
| 4 Jan 2023 | Editorially accepted | |
| 1 Feb 2023 | Article published | 10.1186/s12916-023-02727-8 |
You can find further information about peer review here.